Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women

Item Type:	Article
Title:	Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women
Creators Name:	Cust, A.E. and Kaaks, R. and Friedenreich, C. and Bonnet, F. and Laville, M. and Lukanova, A. and Rinaldi, S. and Dossus, L. and Slimani, N. and Lundin, E. and Tjonneland, A. and Olsen, A. and Overvad, K. and Clavel-Chapelon, F. and Mesrine, S. and Joulin, V. and Linseisen, J. and Rohrmann, S. and Pischon, T. and Boeing, H. and Trichopoulos, D. and Trichopoulou, A. and Benetou, V. and Palli, D. and Berrino, F. and Tumino, R. and Sacerdote, C. and Mattiello, A. and Quiros, J.R. and Mendez, M.A. and Sanchez, M.J. and Larranaga, N. and Tormo, M.J. and Ardanaz, E. and Bueno-de-Mesquita, H.B. and Peeters, P.H. and van Gils, C.H. and Khaw, K.T. and Bingham, S. and Allen, N. and Key, T. and Jenab, M. and Riboli, E.
Abstract:	Adiponectin, an adipocytokine secreted by adipose tissue, is decreased in obesity, insulin resistance, type 2 diabetes, and polycystic ovary syndrome, all of which are well-established risk factors for endometrial cancer.
Keywords:	Adiponectin, Body Mass Index, Case-Control Studies, Endometrial Neoplasms, Postmenopause, Premenopause, Prospective Studies, Risk Factors
Source:	Journal of Clinical Endocrinology and Metabolism
ISSN:	0021-972X
Publisher:	Endocrine Society
Volume:	92
Number:	1
Page Range:	255-263
Date:	January 2007
Official Publication:	https://doi.org/10.1210/jc.2006-1371
PubMed:	View item in PubMed

Repository Staff Only: item control page